Security key
85209E109
Spruce Biosciences, Inc. - Common Stock, par value $0.0001 per share (the "Shares") (SPRB)
CUSIP: 85209E109
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share (the "Shares")
- Total 13F shares
- 2,046,828
- Total 13F value
- $146,574
- Share change
- -8,389,789
- SEC-reported price per share
- $0.07
- Number of holders
- 3
- Value change
- -$2,433,360
- Number of sells
- 26
- Shares outstanding
- 1,373,824
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
3
Top holders
3
SPRB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
SPRUCE BIOSCIENCES, INC. SEC filings
SPRUCE BIOSCIENCES, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 85209E109
Recent filing periods:
Ownership snapshot
Top reported holders of SPRB - Spruce Biosciences, Inc. - Common Stock, par value $0.0001 per share (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RiverVest Venture Fund II...
Disclosed value leader
Carlyle Group Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 4.2%
13D/G row: RiverVest Venture Fund III, L.P.
Showing 1-6 of 15 holder rows.
Quick read
RiverVest Venture Fund III, L.P. leads the comparable SEC ownership view at 4.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RiverVest Venture Fund III, L.P.'s linked filing trail.
Comparable ownership
Top 5
RiverVest Venture Fund III, L.P.
4.2%
Carlyle Group Inc.
211%
Rock Springs Capital Management LP
190%
ACADIAN ASSET MANAGEMENT LLC
76%
Ikarian Capital, LLC
73%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RiverVest Venture Fund III, L.P. |
13D/G
John P. McKearn, Ph.D.
|
4.2%
|
$140,762
1,759,521 shares
|
$0 | 07 Jan 2025 |
| Carlyle Group Inc. |
13F
Company
|
211%
|
$840,280
2,896,518 shares
|
— | 31 Mar 2025 |
| Rock Springs Capital Management LP |
13F
Company
|
190%
|
$756,907
2,609,125 shares
|
— | 31 Mar 2025 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
76%
|
$301,000
1,045,828 shares
|
— | 31 Mar 2025 |
| Ikarian Capital, LLC |
13F
Company
|
73%
|
$290,100
1,000,000 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
61%
|
$244,715
843,844 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
2,046,828
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
30
Q2 2025 holders
3
Holder diff
-27
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend